These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 34900971)
1. Application of Programmable Tetrahedral Framework Nucleic Acid-Based Nanomaterials in Neurological Disorders: Progress and Prospects. Chen X; Xie Y; Liu Z; Lin Y Front Bioeng Biotechnol; 2021; 9():782237. PubMed ID: 34900971 [TBL] [Abstract][Full Text] [Related]
2. Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application. Zhang T; Tian T; Lin Y Adv Mater; 2022 Nov; 34(46):e2107820. PubMed ID: 34787933 [TBL] [Abstract][Full Text] [Related]
3. Progress in Biomedical Applications of Tetrahedral Framework Nucleic Acid-Based Functional Systems. Zhang T; Cui W; Tian T; Shi S; Lin Y ACS Appl Mater Interfaces; 2020 Oct; 12(42):47115-47126. PubMed ID: 32975109 [TBL] [Abstract][Full Text] [Related]
4. Angiogenic Aptamer-Modified Tetrahedral Framework Nucleic Acid Promotes Angiogenesis In Vitro and In Vivo. Zhao D; Liu M; Li J; Xiao D; Peng S; He Q; Sun Y; Li Q; Lin Y ACS Appl Mater Interfaces; 2021 Jun; 13(25):29439-29449. PubMed ID: 34137587 [TBL] [Abstract][Full Text] [Related]
5. [Application of tetrahedral framework nucleic acids in the treatment of osteoarthritis]. Li S; Si H; Shen B Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Apr; 36(4):505-510. PubMed ID: 35426293 [TBL] [Abstract][Full Text] [Related]
6. Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation. Lin Y; Li Q; Wang L; Guo Q; Liu S; Zhu S; Sun Y; Fan Y; Sun Y; Li H; Tian X; Luo D; Shi S Int J Oral Sci; 2022 Oct; 14(1):51. PubMed ID: 36316311 [TBL] [Abstract][Full Text] [Related]
7. Tetrahedral Framework Nucleic Acid Inhibits Chondrocyte Apoptosis and Oxidative Stress through Activation of Autophagy. Shi S; Tian T; Li Y; Xiao D; Zhang T; Gong P; Lin Y ACS Appl Mater Interfaces; 2020 Dec; 12(51):56782-56791. PubMed ID: 33289541 [TBL] [Abstract][Full Text] [Related]
8. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer. Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071 [TBL] [Abstract][Full Text] [Related]
9. Chitosan hydrogel/3D-printed poly(ε-caprolactone) hybrid scaffold containing synovial mesenchymal stem cells for cartilage regeneration based on tetrahedral framework nucleic acid recruitment. Li P; Fu L; Liao Z; Peng Y; Ning C; Gao C; Zhang D; Sui X; Lin Y; Liu S; Hao C; Guo Q Biomaterials; 2021 Nov; 278():121131. PubMed ID: 34543785 [TBL] [Abstract][Full Text] [Related]
10. The Current Progress of Tetrahedral DNA Nanostructure for Antibacterial Application and Bone Tissue Regeneration. Hong S; Jiang W; Ding Q; Lin K; Zhao C; Wang X Int J Nanomedicine; 2023; 18():3761-3780. PubMed ID: 37457798 [TBL] [Abstract][Full Text] [Related]
11. The immune regulatory effects of tetrahedral framework nucleic acid on human T cells via the mitogen-activated protein kinase pathway. Liu X; Yu Z; Wu Y; Shi S; Yao J; Feng X; Wen D; Shi Z; Zhao Z; Li Y; Zhou H; You C; Lin Y; Yang M Cell Prolif; 2021 Aug; 54(8):e13084. PubMed ID: 34170049 [TBL] [Abstract][Full Text] [Related]
12. A Novel Bioswitchable miRNA Mimic Delivery System: Therapeutic Strategies Upgraded from Tetrahedral Framework Nucleic Acid System for Fibrotic Disease Treatment and Pyroptosis Pathway Inhibition. Jiang Y; Li S; Shi R; Yin W; Lv W; Tian T; Lin Y Adv Sci (Weinh); 2024 Jan; 11(1):e2305622. PubMed ID: 37984862 [TBL] [Abstract][Full Text] [Related]
13. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects. Yao Y; Yang M; Shi S Curr Drug Metab; 2023; 24(5):338-352. PubMed ID: 36733192 [TBL] [Abstract][Full Text] [Related]
14. Unleashing Novel Therapeutic Strategies for Dry Eye: Targeting ROS and the cGAS-STING Signaling Pathway with Tetrahedral Framework Nucleic Acids. Yan D; Huang C; Ouyang W; Hu J; Liu Z Adv Healthc Mater; 2024 Dec; 13(30):e2400198. PubMed ID: 39073031 [TBL] [Abstract][Full Text] [Related]
15. Biological Effect of Differently Sized Tetrahedral Framework Nucleic Acids: Endocytosis, Proliferation, Migration, and Biodistribution. Shi S; Li Y; Zhang T; Xiao D; Tian T; Chen T; Zhang Y; Li X; Lin Y ACS Appl Mater Interfaces; 2021 Dec; 13(48):57067-57074. PubMed ID: 34802237 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous DNA hydrogel loaded with Apt02 modified tetrahedral framework nucleic acid accelerated critical-size bone defect repair. Han Y; Wu Y; Wang F; Li G; Wang J; Wu X; Deng A; Ren X; Wang X; Gao J; Shi Z; Bai L; Su J Bioact Mater; 2024 May; 35():1-16. PubMed ID: 38298451 [TBL] [Abstract][Full Text] [Related]
17. Antiepilepticus Effects of Tetrahedral Framework Nucleic Acid via Inhibition of Gliosis-Induced Downregulation of Glutamine Synthetase and Increased AMPAR Internalization in the Postsynaptic Membrane. Zhu J; Yang Y; Ma W; Wang Y; Chen L; Xiong H; Yin C; He Z; Fu W; Xu R; Lin Y Nano Lett; 2022 Mar; 22(6):2381-2390. PubMed ID: 35266400 [TBL] [Abstract][Full Text] [Related]
18. Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier. Shi S; Fu W; Lin S; Tian T; Li S; Shao X; Zhang Y; Zhang T; Tang Z; Zhou Y; Lin Y; Cai X Nanomedicine; 2019 Oct; 21():102061. PubMed ID: 31344499 [TBL] [Abstract][Full Text] [Related]
19. Liver-Targeted Delivery of Small Interfering RNA of C-C Chemokine Receptor 2 with Tetrahedral Framework Nucleic Acid Attenuates Liver Cirrhosis. Tian T; Zhao C; Li S; Huang Z; Guo Y; Dai W; Bai R; Tang C; Lin Y; Gao J ACS Appl Mater Interfaces; 2023 Mar; 15(8):10492-10505. PubMed ID: 36799737 [TBL] [Abstract][Full Text] [Related]
20. Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma. Fu W; You C; Ma L; Li H; Ju Y; Guo X; Shi S; Zhang T; Zhou R; Lin Y ACS Appl Mater Interfaces; 2019 Oct; 11(43):39525-39533. PubMed ID: 31601097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]